Stephen B. Bonner Assumes New Role as CTCA Executive Chairman, Gerard van Grinsven Succeeds as President & CEO

SCHAUMBURG, Ill., April 26, 2013 /PRNewswire/ -- Cancer Treatment Centers of America® (CTCA) announced today a change in its executive leadership as part of its ongoing commitment to remain in the vanguard of innovation in healthcare and deliver the best possible care for cancer patients.

(Photo: http://photos.prnewswire.com/prnh/20130426/NY02744 )

Stephen B. Bonner, President & Chief Executive Officer (CEO) since 1999, will assume the new role of Executive Chairman effective July 1, at which time Gerard van Grinsven will assume the role of President & CEO. In his new role, Bonner will continue to serve as the senior executive of CTCA responsible for preparing van Grinsven to succeed him and leading the company's Value Commitment Strategic Objectives. Bonner will also manage the company's financial relationships, the charitable activities of The Gateway for Cancer Research and the operations of Cancer Nutrition Centers of America. All other corporate functions will report to van Grinsven.

For the past seven years, van Grinsven has served as President & CEO of the Henry Ford West Bloomfield Hospital in Detroit. During that time, he was widely recognized and applauded for his innovations in clinical excellence, patient satisfaction and facility design. Prior to his tenure at the Henry Ford, van Grinsven held several executive positions with the Ritz-Carlton, Peninsula, and Mandarin Oriental hotel companies.

"Gerard's arrival is an exciting and dramatic step in the evolution of our leadership that will herald new opportunities for all of our talented Stakeholders and the thousands of patients we serve," said Bonner. "Our expertise in Patient Empowerment Medicine® and track record implementing change is unparalleled. Nothing we do today is the same as we did two years ago. Gerard is uniquely qualified to provide the leadership required to advance our commitment to patient-centered care in all we do," concluded Bonner.

"I'm eager to join the innovative leaders and stakeholders of CTCA to help expedite their journey to become the leader in personalized and precision cancer care, while making a real and lasting difference in the lives of patients fighting complex or advanced-stage cancer," said van Grinsven.

"CTCA is 'always and only about the patient.' We built a path to a better future for thousands of patients by surrounding them with the very best clinical talent, the latest technology, and the most comprehensive treatment options," said Richard J. Stephenson, Founder and Chairman of the CTCA Board. "We have always encouraged innovative and dynamic deployment of our wonderful talent, and are very excited about the exemplary leadership we know Gerard will bring to this tradition in the years ahead," Stephenson stated.

About Cancer Treatment Centers of America:
Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals focusing on complex and advanced stage cancer. CTCA offers a comprehensive, fully integrated approach to cancer treatment and serves patients from all 50 states at facilities located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine, CTCA provides patients with information about cancer and their treatment options so they can control their treatment decisions. For more information about CTCA, go to www.cancercenter.com.

Contact:



Pamela Browner White


Pamela.white@ctca-hope.com


847-342-7303




Angela Salerno


Angela.salerno@edelman.com


312-233-1243

SOURCE Cancer Treatment Centers of America



RELATED LINKS
http://www.cancercenter.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.